Skip to content

Checked

Class IIIDrug recallOngoing

Fexofenadine Hydrochloride Tablets recall

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC of Princeton, NJ · FDA report 07/08/2026

Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.

Class
Class III
Low risk
Status
Ongoing
Recall started
06/01/2026
Distribution
Nationwide

Reason for recall

Failed Impurities/Degradation Specifications

Class III: Use of or exposure to the product is not likely to cause adverse health consequences.

Recalled product

Product
Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30
Lot and code info
Lot, expiry: Lot DNG0283A, exp 03/31/2027; Lots DNF0922A and DNF0923B, exp 10/31/2026
Quantity
9,048 bottles
Recall number
D-0654-2026
Event ID
99110
Initiated by
Voluntary: Firm initiated

Where it was distributed

U.S. Nationwide

  • Nationwide

Recall timeline

  1. 06/01/2026Firm started the recall
  2. 06/30/2026FDA classified it as Class III
  3. 07/08/2026Published in the FDA enforcement report

More recalls from SUN PHARMACEUTICAL INDUSTRIES

Frequently asked questions

Why was Fexofenadine Hydrochloride Tablets recalled?
Failed Impurities/Degradation Specifications
What does Class III mean?
Class III is FDA's low risk recall category: use of or exposure to the product is not likely to cause adverse health consequences.
Where was the recalled product sold?
U.S. Nationwide
Is this recall still active?
The FDA lists the recall as ongoing. The recall is still in progress.

Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 07/08/2026 · Do not rely on openFDA to make decisions regarding medical care